DIABETOLOGY & CARDIOLOGY: THE FUTURE IS NOW!

Abstract

In July 2019 the American Board of Internal Medicine published a position statement in which a new sub-specialty alongside a new training curriculum was proposed: cardiometabolic medicine. This new sub-specialty is a natural advance in the collaboration between two twinned medical specialties: diabetology and cardiology. The links between the two specialties are more evident as a continuous body of evidence is building regarding a long set of inter- connections. For a long time the links between the two specialties were considered merely based on the macro-vascular complications arising in patient with Type 2 Diabetes Mellitus (T2DM); in the early era of diabetes knowledge it was hypothesized that the macro-vascular complications arisen mainly due to an improper glycemic control associated to the presence of T2DM. Nowadays, the paradigm is progressively changing, and the arising evidences are pointing to common pathogenic pathways between T2DM, atherosclerotic cardiovascular diseases or heart failure.